
|Videos|August 9, 2022
Available Monotherapies and Combination Therapies in mCSPC
Author(s)Jason Hafron, MD
An expert provides an overview of the types of androgen deprivation therapy (ADT) for mCSPC, other therapies that can be used in combination with ADT for treatment intensification and compares the safety and efficacy of the various regimens.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Retrospective study suggests differences in OAB therapy persistence among older adults
4
Microbial dysbiosis may predict response to CBM588 in mRCC
5












